Image_1_Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.PDF by Nicole C. McCoy (12459036)

“…The implementation group showed significantly reduced median intraoperative (20.0 mg vs. 0.0 mg; p < 0.001) and total opioid consumption (20.5 mg vs. 0.0 mg; p < 0.001). The number of patients who received any opioids decreased from 84.2% (16/19) before implementation to 23.1% (3/13) after implementation.…”

Image_3_Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.PDF by Nicole C. McCoy (12459036)

“…The implementation group showed significantly reduced median intraoperative (20.0 mg vs. 0.0 mg; p < 0.001) and total opioid consumption (20.5 mg vs. 0.0 mg; p < 0.001). The number of patients who received any opioids decreased from 84.2% (16/19) before implementation to 23.1% (3/13) after implementation.…”

Directed Evolution of RecA Variants with Enhanced Capacity for Conjugational Recombination by Taejin Kim (472963)

“…Three of the variant proteins, RecA I102L, RecA V79L and RecA E86G/C90G were characterized based on their prominence. …”

NeuroD1 suppresses lipid ROS level in HCC. by Ping Huang (30439)

VEGFq treatment decreases newly transcribed <i>VEGF</i> mRNA and protein expression and downstream ERK1/2 and AKT mediated signaling. by David Muench (1343364)

“…(C) Time course of ERK 1/2 / p-ERK 42/44 and (D) AKT / p-AKT Ser 473 protein expression after 24-144h of 10μM VEGFq or MutVEGF treatment as determined by Western analysis. …”

<i>Abhd2</i> deletion decreased hepatic phosphatidylglycerol concentrations but did not alter mitochondrial gene expression or mitochondrial lipid acyl chain compositions. by Tara R. Price (16715660)

“…However, total phosphatidylglycerol concentrations were decreased Abhd2^KO mice compared to WT males (p<0.01). …”

Percentage of lesions within reach of different sized tools if the tool remains inside the airways. by Torre M. Bydlon (295015)

Difference in 3 month growth outcomes by treatment arm stratified by pathogen detection at 6 and 12 months of age. by Godfrey Guga (12152390)

<b>Reduced legacy precipitation decreases microbial community growth efficiency and alters soil organic carbon in a California grassland</b> by Linnea Honeker (13113813)

ESX-5-dependent surface proteins of <i>M</i>. <i>marinum</i>. by Louis S. Ates (734423)

“…Shown here are only proteins with at least a five-fold decrease in spectral counts in the Δ<i>esx-5</i>::<i>mspA</i> strain. …”

<i>miR-142</i> ablation impairs suppressive function and homeostasis of T_reg cells. by Wei-Le Wang (133402)

Embryonic <i>Shroom3</i>^{<i>Gt</i>/<i>Gt</i>} hearts show abnormal semilunar valves. by Jennifer L. Carleton (22208916)

Assessment of the protective efficacy of SinH-based vaccines reduced the mortality of ExPEC sequence type 131 (ST131) bacteremia. by Yikun Xing (9427893)

Reservoir and pVL dynamics for the parameter set that best reproduced the year 11.4 ART clone profile. by John M. Murray (150672)

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”

Complete ELICIT TAC data. by Godfrey Guga (12152390)

“…We tested 5,479 stool samples at time points across the study for 34 enteropathogens using quantitative PCR.…”

ELICIT TAC data dictionary. by Godfrey Guga (12152390)

“…We tested 5,479 stool samples at time points across the study for 34 enteropathogens using quantitative PCR.…”

Early Stages of Sea-Level Rise Lead To Decreased Salt Marsh Plant Diversity through Stronger Competition in Mediterranean-Climate Marshes - Fig 2 by Akana E. Noto (3623366)